Toggle Offcanvas
...
 
Immunosuppressive Agents Bids and RFPs

Immunosuppressive Agents Bids and RFPs

Latest Immunosuppressive Agents RFPs, bids and solicitations. Bid on readily available Immunosuppressive Agents contracts with the best and most comprehensive government procurement platform, since 2002.

Bidding for Immunosuppressive Agents RFPs is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Immunosuppressive Agents.

Global Tenders stands out as the largest platform dedicated to bids and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Bids/Contracts/Solicitations Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to bid information, we offer in-depth Immunosuppressive Agents market research, procurement analysis, historical archives, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Immunosuppressive Agents rfps, advanced search filters, market analysis, industry trends, bid training and 24/7 customer support.

19 Live Notices for Immunosuppressive Agents Bids and RFPs

Showing 1 to 19

Medicinal Products Containing Fallen, Methotrexate And Azathioprin
country Czech Republic
posting date05 Jun 2025
deadline07 Jul 2025
Lp Containing Adalimumab 2025
country Czech Republic
posting date02 Jun 2025
deadline03 Jul 2025
Un Motol - Tilldrakizumab 200 Mg
country Czech Republic
posting date02 Jun 2025
deadline11 Jun 2025
Delivery Of Anti -Cancer Agents, Funds Immunosuppressive, Immunoglobulin, Divided Into 14 Parts. Mark Of The Case: Zp.26.36.2025.Kch
country Poland
posting date30 May 2025
deadline01 Jul 2025
Drug Supply - The Active Substance Golimumab - Atc L04Ab06
country Czech Republic
posting date28 May 2025
deadline27 Jun 2025
Dns - Filgotinib
country Czech Republic
posting date27 May 2025
deadline11 Jun 2025
Immunosuppressant - Inhibitor To The Pagcetacoplan I. Complement I.
country Czech Republic
posting date20 May 2025
deadline16 Jun 2025
Immunosuppressant - Inhibitor To The Pagcetacoplan I. Complement I.
country Czech Republic
posting date20 May 2025
deadline16 Jun 2025
Immunosuppressant - Inhibitor To The Pagcetacoplan I. Complement I.
country Czech Republic
posting date19 May 2025
deadline16 Jun 2025
Lp Containing Anagrelide 2025
country Czech Republic
posting date19 May 2025
deadline20 Jun 2025
Purchase Of Medicines Haridi Mavodҳoy Doruvorӣ
country Tajikistan
posting date16 May 2025
deadline06 Jun 2025
Drug Supply - The Active Substance Ofatumumab - Atc L04Ag12
country Czech Republic
posting date06 May 2025
deadline06 Jun 2025
Delivery Of Medicinal Products To Drug Programs, Various Medicines, Medical Devices And Various Products
country Poland
posting date29 Apr 2025
deadline04 Jun 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia
country Spain
posting date30 Dec 2024
deadline01 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).
country Germany
posting date10 Nov 2023
deadline27 Oct 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).
country Germany
posting date22 Sep 2023
deadline27 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).
country Germany
posting date14 Aug 2023
deadline28 Jul 2025

Share Share this page